Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of eravacycline vs meropenem in complicated intra-abdominal infections
2016-002208-21Phase 3Completed
- Sponsor
- Tetraphase Pharmaceuticals, Inc.
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of eravacycline in Intra-abdominal infection (IAI) (2 arms), sponsored by Tetraphase Pharmaceuticals, Inc. Primary endpoint: Clinical response at test-of-cure in micro-ITT population. Started Jul 2016; status: completed.
02
Drugs
eravacycline
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on 2016-002208-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002208-21.